Healthcare - Biotechnology - NASDAQ - CN
$ 1.04
-2.8 %
$ 80.1 M
Market Cap
-0.46
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
--6.17%
EBIT
Estimate
71.51%
Net Income
Estimate
27.40%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
I-Mab
IMAB has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart IMAB
EBIT FORECAST
EBIT Forecast Chart IMAB
NET INCOME FORECAST
Net Income Chart IMAB